Literature DB >> 1331936

Activation of Jun/AP-1 by protein kinase A.

R P de Groot1, P Sassone-Corsi.   

Abstract

The product of the c-jun proto-oncogene is the major component of the 12-O-tetradecanoyl phorbol 13-acetate (TPA)-inducible transcription factor AP-1. Jun binds to the TPA-responsive elements (TREs) present in a large number of TPA-inducible genes, thereby regulating their expression in response to activation of protein kinase C. Previously we have shown that Jun/AP-1 can also activate cAMP-responsive elements (CREs), indicating the existence of cross-talk in signal transduction at the transcriptional level. Here we show that Jun/AP-1 is activated by the cAMP-dependent protein kinase A (PKA). In transient transfection experiments, TRE activation by Jun is strongly enhanced by co-transfection of the catalytic subunit of PKA or forskolin treatment, although not in all cell types studied. Jun activity can be significantly inhibited by co-transfection of the regulatory subunit of PKA. Furthermore, we show a cell-specific increase in AP-1 binding in response to forskolin treatment. However, since direct phosphorylation of Jun by PKA does not occur, we suggest an indirect activation mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331936

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

2.  Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain-interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation.

Authors:  Hsin-Chieh Lan; Hua-Jung Li; Guang Lin; Pao-Yen Lai; Bon-chu Chung
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

3.  Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4.

Authors:  B Viollet; A Kahn; M Raymondjean
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  beta-adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta.

Authors:  A M Colangelo; P F Johnson; I Mocchetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

5.  Expression of the genes encoding CCAAT-enhancer binding protein isoforms in the mouse mammary gland during lactation and involution.

Authors:  G Sabatakos; G E Davies; M Grosse; A Cryer; D P Ramji
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

6.  Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.

Authors:  U Dendorfer; P Oettgen; T A Libermann
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

7.  Tissue-specific and ubiquitous factors binding next to the glucocorticoid receptor modulate transcription from the mouse mammary tumor virus promoter.

Authors:  C Cavin; E Buetti
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 8.  Goals for signal transduction pathways: linking up with transcriptional regulation.

Authors:  P Sassone-Corsi
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

9.  The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.

Authors:  A M Richter; S K Walesch; P Würl; H Taubert; R H Dammann
Journal:  Oncogenesis       Date:  2012-06-25       Impact factor: 7.485

10.  Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1.

Authors:  J J Hwang; P Chambon; I Davidson
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.